My LFT is slightly high, but I feel fine”: Doctors explain when borderline liver reports turn dangerous and what should be the immediate preventive measures

LFT slightly high. There is no pain. No yellowing of the eyes. No weakness. So it is easy to brush it aside. But the liver ...

Fatty liver: The problem most people find by accident

Many people discover they have fatty liver disease during a routine health check-up. They walk into a clinic for a regular ...

Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders

The lead drug candidate, ALN1003, showed dose-related body weight loss and favorable body composition changes in the DIO mouse modelALN1003 also ...

Moringa Leaves Can Help Lower Fatty Liver Risk; Here's How

Studies suggest that moringa leaves can help protect the liver from damage due to toxins and diseases. They may promote liver ...

Alaunos Therapeutics, Inc.: Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and ...

The lead drug candidate, ALN1003, showed dose-related body weight loss and favorable body composition changes in the DIO mouse modelALN1003 also demonstrated reductions in liver weight and improvement ...

Hepatitis myths busted: What we get wrong about liver disease in India

Is hepatitis always caused by alcohol? Does it spread through touch or food? Can herbal remedies cure it? A ...
Nature

High risk of liver disease in women with polycystic ovary syndrome

One in four women with polycystic ovary syndrome (PCOS) may have nonalcoholic steatohepatitis (NASH), the most severe form of nonalcoholic fatty liver disease (NAFLD), according to an article ...
Fierce Biotech

Lynk points to phase 3 eczema win as more proof of next-gen JAK inhibitor's potential

Lynk Pharmaceuticals has reported another phase 3 win in China for its next-gen JAK inhibitor, this time hitting skin clearance goals among patients with eczema. | Lynk Pharmaceuticals has reported ...
Medical Dialogues

Over One in Four Young Indian Adults Have MASLD, Population-Based Study Reports

India: A recent study published in the Journal of Clinical and Experimental Hepatology in June 2025 reports a high prevalence of transaminitis (25.9 percent) among young Indian adults, and that 27.4 ...

Ainos, Inc.: Ainos Reports Statistically Significant Interim Efficacy Results from VELDONA Clinical Trial in Feline Chronic Gingivostomatitis

Open-Label Study Demonstrates Durable Reduction in Oral Inflammation with Favorable Tolerability Profile at Interim Analysis HOUSTON, TEXAS / ACCESS Newswire / February 17, 2026 / Ainos, Inc. (NASDAQ: ...

Ainos Reports Statistically Significant Interim Efficacy Results from VELDONA Clinical Trial in Feline Chronic Gingivostomatitis (FCGS)

The study is designed to enroll 12 client-owned cats diagnosed with FCGS across two dosing cohorts (6,000 IU and 12,000 IU administered orally three times per week for six weeks). The interim analysis ...